Liver Cancer

Published by: Karger  

People

  1. Abou-Alfa
    Abou-Alfa
  2. Do
    Do
  3. Harding
    Harding
  4. O'Reilly
    O'Reilly
  5. Solit
    Solit

Groups

  1. Advanced Practice Providers (1)
  2. Body Imaging Service (1)
  3. Center for Pancreatic Cancer Research (1)
  4. Department of Medicine (1)
  5. GSK Faculty (1)
  6. Gastrointestinal Oncology Service (1)
  7. Genitourinary Oncology Service (1)
  8. Human Oncology and Pathogenesis Program (1)
  9. Nursing (1)
  10. Radiology, Department of (1)
Search Within
  1. "GSK Faculty"
Formats
  1. Journal Article (1)
Groups
  1. Advanced Practice Providers (1)
  2. Body Imaging Service (1)
  3. Center for Pancreatic Cancer Research (1)
  4. Department of Medicine (1)
  5. GSK Faculty (1)
  6. Gastrointestinal Oncology Service (1)

More Groups

People
  1. Alison O'Neill (1)
  2. Amin Yaqubie (1)
  3. David Solit (1)
  4. Eileen O'Reilly (1)
  5. Ghassan Abou-Alfa (1)
  6. James Harding (1)

More People

Years
  1. 2025 (1)
Publishers
  1. Karger (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neratinib alone or in combination with immune checkpoint inhibitors with or without mammalian target of rapamycin inhibitors in patients with fibrolamellar carcinoma
    Journal Article

    Abou-Alfa, G. K.; Meyer, T.; Do, R. K. G.; Piha-Paul, S. A.; Light, J. S.; Sherrin, S.; Yaqubie, A.; O'Neill, A. C.; Harding, J. J.; Al-Rajabi, R.; more...
    Liver Cancer (2025)

    Fulltext@MSK | Save

    • Liver Cancer – authorized name for:

    Name ISSN / ISBN Publisher
    Liver Cancer 22351795 S. Karger AG
    Liver Cancer 2235-1795 Karger
    Liver Cancer 2235-1795 Karger
    Liver Cancer 2235-1795 Karger
    Liver Cancer 22351795 Authors
    Liver Cancer 22351795 The Author(s)
    Liver Cancer 22351795 S. Karger AG